| Name | Title | Contact Details |
|---|---|---|
Marie-Pierre Herve |
FMCG Global Marketing Director | Profile |
Ely Bar Ness |
Chief human resources officer | Profile |
Patrick Kane |
Vice President of Sales | Profile |
Berenice Gonzales |
Global Director, Integrated Marketing | Profile |
Monica Mayer |
Senior Director, Indirect Procurement | Profile |
Kiss Products Inc is a Port Washington, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SlimGenics Weight Control Center - Aurora is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Based in City of Industry, California, Markwins® International Corporation is a global leader in color cosmetics, cosmetic accessories, and beauty collections. Founded by CEO Eric Chen 30 years ago, the privately-held company is recognized as a Top 20 purveyor in the global cosmetic industry. With over 5,000 employees, Markwins® brands cater to and reach consumers of all ages, ethnicities, economic statuses, and skin tones. The Markwins® brand portfolio includes wet n wild®, Physicians Formula®, Bonne Bell®, Lip Smacker®, The Color Workshop®, The Color Institute®, Black Radiance®, and POP®, amongst many other internal brands and licensing deals. Markwins® brands can be found in over 50,000 retail outlets including Department, Specialty, Mass, Drug, and Food stores, and are available in more than 60 countries, spanning 6 continents.
Harmony Laboratories Inc is a Kannapolis, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla`s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla`s research and development focuses on developing innovative products and drug delivery systems.